ACE and pachyonychia congenita: The prospect of repurposed inexpensive and well-tolerated medications, such as ARBs and ACE inhibitors, having an impact on survival in PC patients is certainly intriguing from a clinical standpoint – especially considering that there are so few effective interventions available for PC patients, besides surgical resection when possible.